ZA793603B - The method of treating malignancies by administering sarcosine,its derivatives and mixtures - Google Patents

The method of treating malignancies by administering sarcosine,its derivatives and mixtures

Info

Publication number
ZA793603B
ZA793603B ZA00793603A ZA793603A ZA793603B ZA 793603 B ZA793603 B ZA 793603B ZA 00793603 A ZA00793603 A ZA 00793603A ZA 793603 A ZA793603 A ZA 793603A ZA 793603 B ZA793603 B ZA 793603B
Authority
ZA
South Africa
Prior art keywords
sarcosine
derivatives
administering
mixtures
tumor
Prior art date
Application number
ZA00793603A
Other languages
English (en)
Inventor
Mahmoud Youssef
Youssef Mahmoud
H Osswald
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Publication of ZA793603B publication Critical patent/ZA793603B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Surgical Instruments (AREA)
  • Toys (AREA)
  • Window Of Vehicle (AREA)
ZA00793603A 1978-07-20 1979-07-17 The method of treating malignancies by administering sarcosine,its derivatives and mixtures ZA793603B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782832009 DE2832009A1 (de) 1978-07-20 1978-07-20 Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Publications (1)

Publication Number Publication Date
ZA793603B true ZA793603B (en) 1980-07-30

Family

ID=6044955

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00793603A ZA793603B (en) 1978-07-20 1979-07-17 The method of treating malignancies by administering sarcosine,its derivatives and mixtures

Country Status (13)

Country Link
US (1) US4766149A (xx)
EP (1) EP0007597B1 (xx)
JP (1) JPS5519270A (xx)
AT (1) ATE11220T1 (xx)
AU (1) AU529657B2 (xx)
CA (1) CA1151065A (xx)
DD (1) DD144864A5 (xx)
DE (1) DE2832009A1 (xx)
DK (1) DK305479A (xx)
FI (1) FI792218A (xx)
MC (1) MC1271A1 (xx)
NO (1) NO792398L (xx)
ZA (1) ZA793603B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3050800C2 (xx) * 1979-03-22 1989-06-22 Continental Pharma Inc., Bruessel/Bruxelles, Be
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
US4994492A (en) * 1989-01-09 1991-02-19 Foodscience Corporation Treatment of melanoma using N,N-dimethylglycine
US5676978A (en) * 1989-02-14 1997-10-14 Amira, Inc. Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
DE4026184A1 (de) * 1990-08-18 1992-02-20 Henkel Kgaa Verfahren zur verminderung des restgehaltes an freiem alkylierungsmittel in waessrigen loesungen kationischer tenside
EP1513419A2 (en) * 2002-06-19 2005-03-16 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
US8697679B2 (en) * 2003-03-07 2014-04-15 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
EP1847274A1 (en) * 2006-04-21 2007-10-24 CIPROSA LLC - Corporate Creations Network, Inc. Association of phenylbutyrate, ATRA and cytidine and its use in anti-tumour therapy
EP3415910A1 (en) 2017-06-16 2018-12-19 Prevention Medicals s.r.o. A method of quantitative determination of sarcosine in a biological sample using anti-arcosine antibodies and peroxidase-active gold nanoparticles or quantum dots

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE553424C (de) * 1928-04-18 1932-06-27 Karl Luedecke Dr Verfahren zur Herstellung von Praeparaten, die das Wachstum von Geweben durch Verminderung der Teilungsfaehigkeit oder Aufloesung der wuchernden Zellen einschraenken
BE647556A (xx) * 1964-05-06 1964-08-31
FR2085637A1 (fr) * 1970-04-15 1971-12-31 Etude Des Catalyseurs Soc D Composition pharmaceutique utilisable notamment contre l'asthenie
DE2211019C3 (de) * 1972-03-08 1980-08-28 Bayer Ag, 5090 Leverkusen Geschmacksverbessernde Formulierungen oraler Penicilline

Also Published As

Publication number Publication date
FI792218A (fi) 1980-01-21
DE2832009C2 (xx) 1988-07-28
AU529657B2 (en) 1983-06-16
DK305479A (da) 1980-01-21
EP0007597A1 (de) 1980-02-06
JPS5519270A (en) 1980-02-09
US4766149A (en) 1988-08-23
ATE11220T1 (de) 1985-02-15
EP0007597B1 (de) 1985-01-16
MC1271A1 (fr) 1980-05-23
DD144864A5 (de) 1980-11-12
AU4907679A (en) 1980-01-24
DE2832009A1 (de) 1980-01-31
NO792398L (no) 1980-01-22
CA1151065A (en) 1983-08-02

Similar Documents

Publication Publication Date Title
ZA793603B (en) The method of treating malignancies by administering sarcosine,its derivatives and mixtures
ES8302681A1 (es) Un metodo para preparar derivados de fenilpiperazina
ES478047A1 (es) Procedimiento para la obtencion de acidos 4-piridon-3-car- boxilicos.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
IE44855L (en) Meat treating composition.
JPS5256A (en) Sediment-contained water treating method
DE3066443D1 (en) Composition and method for inhibiting the formation of nitrosamine in organic amines by addition of 1,4-naphthoquinone, 1,4-naphthohydroquinone or alkyl derivatives thereof
JPS5443172A (en) Treating method for chromium-containing material
IL79055A0 (en) 1,1,2,2-tetramethyl-1,2-bis-(2-fluoro-4-hydroxyphenyl)-ethane derivatives and pharmaceutical compositions containing them
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
SE8402172D0 (sv) Magnetisk kropp
DE3662693D1 (en) 1-methyl-15-alpha-alkyl-androsta-1,4-diene-3,17-diones, process for their preparation and pharmaceutical compositions containing them
ZA872276B (en) Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds
ZA859481B (en) Process for the preparation of alpha-aminoalkylphosphonic and of alpha-aminoalkylphosphinic acids
JPS5256451A (en) Apparatus for concentrating the slurry
DE3362451D1 (en) Alkylated vicinal toluenediamines and their use as chain extenders in the preparation of polyurethane-polyurea elastomers
ES2004436A6 (es) Procedimiento para blanquear y aumentar la capacidad de intercambio ionico de la sepiolita
FR2500441B1 (xx)
SU1072420A1 (ru) Бис-[(3,5-ди-трет-бутил-4-оксифенил)-алкил]-сульфиды в качестве термостабилизаторов полиэтилена
BR7800644A (pt) Composicao fertilizante para fornecimento de ferro micronutriente a plantas,processo para a mesma finalidade,plantas assim tratadas,e processo para preparacao de novos prussiatos
GB1518079A (en) Benzanilide derivatives and their fungicidal and bactericidal uses
JPS535852A (en) Process for treating sludge
GB1443406A (en) Purification of coumarin and alkylated derivatives thereof
JPS5665984A (en) Corrosion inhibitor
JPS6434368A (en) Deodorant